JP2002507391A - 繊維ノブのhiループに異種ペプチドエピトープを含有するアデノウイルスベクター - Google Patents

繊維ノブのhiループに異種ペプチドエピトープを含有するアデノウイルスベクター

Info

Publication number
JP2002507391A
JP2002507391A JP2000530231A JP2000530231A JP2002507391A JP 2002507391 A JP2002507391 A JP 2002507391A JP 2000530231 A JP2000530231 A JP 2000530231A JP 2000530231 A JP2000530231 A JP 2000530231A JP 2002507391 A JP2002507391 A JP 2002507391A
Authority
JP
Japan
Prior art keywords
fiber
cells
adenovirus
gene
knob
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000530231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002507391A5 (cg-RX-API-DMAC10.html
Inventor
ティー カリエル,デイヴィッド
エヌ クラスニフ,ヴィクター
デミトリエフ,アイガー
Original Assignee
ザ ユーエイビー リサーチ ファンデイション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ ユーエイビー リサーチ ファンデイション filed Critical ザ ユーエイビー リサーチ ファンデイション
Publication of JP2002507391A publication Critical patent/JP2002507391A/ja
Publication of JP2002507391A5 publication Critical patent/JP2002507391A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
    • C12N2710/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
JP2000530231A 1998-02-06 1999-02-05 繊維ノブのhiループに異種ペプチドエピトープを含有するアデノウイルスベクター Pending JP2002507391A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7394798P 1998-02-06 1998-02-06
US60/073,947 1998-02-06
US9980198P 1998-09-10 1998-09-10
US60/099,801 1998-09-10
PCT/US1999/002549 WO1999039734A1 (en) 1998-02-06 1999-02-05 Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob

Publications (2)

Publication Number Publication Date
JP2002507391A true JP2002507391A (ja) 2002-03-12
JP2002507391A5 JP2002507391A5 (cg-RX-API-DMAC10.html) 2006-03-30

Family

ID=26755086

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000530231A Pending JP2002507391A (ja) 1998-02-06 1999-02-05 繊維ノブのhiループに異種ペプチドエピトープを含有するアデノウイルスベクター

Country Status (11)

Country Link
US (1) US7297542B2 (cg-RX-API-DMAC10.html)
EP (1) EP1053013A4 (cg-RX-API-DMAC10.html)
JP (1) JP2002507391A (cg-RX-API-DMAC10.html)
KR (1) KR20010034487A (cg-RX-API-DMAC10.html)
CN (1) CN1304316A (cg-RX-API-DMAC10.html)
AU (1) AU744252B2 (cg-RX-API-DMAC10.html)
BR (1) BR9908613A (cg-RX-API-DMAC10.html)
CA (1) CA2327545A1 (cg-RX-API-DMAC10.html)
IL (1) IL137681A0 (cg-RX-API-DMAC10.html)
NO (1) NO20003956L (cg-RX-API-DMAC10.html)
WO (1) WO1999039734A1 (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006514538A (ja) * 2002-07-10 2006-05-11 トランスジーン ソシエテ アノニム 細胞受容体への結合が除去された改変アデノウイルス繊維
JP2015511822A (ja) * 2012-03-13 2015-04-23 ソーク インスティテュート フォー バイオロジカル スタディーズ アデノウイルスおよび化学二量体を用いる選択細胞の標的化

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395875B1 (en) * 1999-01-25 2002-05-28 Brookhaven Science Associates Llc Recombinant soluble adenovirus receptor
US7157266B2 (en) * 1999-01-25 2007-01-02 Brookhaven Science Associates Llc Structure of adenovirus bound to cellular receptor car
CA2392272A1 (fr) * 1999-11-25 2001-05-31 Transgene S.A. Fibre adenovirable modifiee et utilisations
JP5043271B2 (ja) 2000-04-12 2012-10-10 ジーイー・ヘルスケア・アクスイェ・セルスカプ ペプチドベースの化合物
JP2003534805A (ja) 2000-05-31 2003-11-25 ユニバーシティ オブ サスカチュワン 変化した親和性を有する改変ウシアデノウイルス
JP3635462B2 (ja) 2000-05-31 2005-04-06 国立医薬品食品衛生研究所長 アデノウイルスベクター
NO20004795D0 (no) 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
CN1622830A (zh) 2001-07-10 2005-06-01 安盛药业有限公司 肽基化合物
EP1446479B1 (en) 2001-09-29 2012-08-15 Chae-Ok Yun Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus
US20060281090A1 (en) * 2003-05-01 2006-12-14 University Of Washington Uw Tech Transfer- Invention Licensing Capsid-modified adenovirus vectors and methods of using the same
CA2524499A1 (en) * 2003-05-14 2004-11-25 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa Broadening adenovirus tropism
WO2005040333A2 (en) * 2003-10-24 2005-05-06 National Research Council Of Canada Ligand-pseudoreceptor system for generation of adenoviral vectors with altered tropism
EP1720636A4 (en) 2004-02-02 2012-06-20 Univ British Columbia SCODAPHORESIS AND METHOD AND DEVICES FOR MOVING AND CONCENTRATING PARTICLES
US10337054B2 (en) 2004-02-02 2019-07-02 Quantum-Si Incorporated Enrichment of nucleic acid targets
US8529744B2 (en) 2004-02-02 2013-09-10 Boreal Genomics Corp. Enrichment of nucleic acid targets
US9186685B2 (en) 2012-01-13 2015-11-17 The University Of British Columbia Multiple arm apparatus and methods for separation of particles
US8518228B2 (en) 2011-05-20 2013-08-27 The University Of British Columbia Systems and methods for enhanced SCODA
US7473418B2 (en) 2004-03-25 2009-01-06 Cell Genesys, Inc. Pan cancer oncolytic vectors and methods of use thereof
DE102004021584A1 (de) * 2004-05-03 2005-12-01 Stefan Kochanek Modifizierte virale Vektorpartikel
US7776322B2 (en) 2004-08-16 2010-08-17 Stefan Kochanek Modified viral vector particles
CA2496294A1 (en) * 2005-02-07 2006-08-07 The University Of British Columbia Apparatus and methods for concentrating and separating particles such as molecules
WO2007123737A2 (en) 2006-03-30 2007-11-01 University Of California Methods and compositions for localized secretion of anti-ctla-4 antibodies
US7919079B2 (en) 2006-03-31 2011-04-05 Biosante Pharmaceuticals, Inc. Cancer immunotherapy compositions and methods of use
US20100272753A1 (en) * 2006-10-26 2010-10-28 The Johns Hopkins University Recombinant Adenovirus Vaccines
CA2713313A1 (en) * 2008-02-01 2009-08-06 The University Of British Columbia Methods and apparatus for particle introduction and recovery
US8791239B2 (en) * 2008-05-04 2014-07-29 University Of Maryland, College Park Fibrous assemblies for antibody presentation, and multiplexed antigenic analysis using same
JP2012513589A (ja) 2008-12-23 2012-06-14 ジーイー・ヘルスケア・リミテッド 骨髄イメージング剤としての99mTc−ペプチド系化合物の応用
WO2010121381A1 (en) 2009-04-21 2010-10-28 The University Of British Columbia System and methods for detection of particles
ES2385251B1 (es) 2009-05-06 2013-05-06 Fundació Privada Institut D'investigació Biomèdica De Bellvitge Adenovirus oncolíticos para el tratamiento del cáncer.
US9458473B2 (en) * 2010-06-29 2016-10-04 The Johns Hopkins University Compositions and methods for retargeting virus constructs
EP2798069B1 (en) * 2011-12-15 2017-03-29 Washington University Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection
WO2013166444A2 (en) 2012-05-04 2013-11-07 Boreal Genomics Corp. Biomarker analysis using scodaphoresis
SG11201507393TA (en) 2013-03-14 2015-10-29 Salk Inst For Biological Studi Oncolytic adenovirus compositions
US9340835B2 (en) 2013-03-15 2016-05-17 Boreal Genomics Corp. Method for separating homoduplexed and heteroduplexed nucleic acids
CN104634978A (zh) * 2013-11-13 2015-05-20 长春百克生物科技股份公司 一种分型检测腺病毒中和抗体的方法以及用于分型检测腺病毒中和抗体的试剂盒
US20160058889A1 (en) * 2014-08-11 2016-03-03 The Board Of Regents Of The University Of Texas System Prevention of muscular dystrophy by crispr/cas9-mediated gene editing
ES2899913T3 (es) 2014-09-24 2022-03-15 Salk Inst For Biological Studi Virus tumorales oncolíticos y métodos de uso
WO2016185284A1 (en) 2015-05-20 2016-11-24 Boreal Genomics, Inc. Method for isolating target nucleic acid using heteroduplex binding proteins
EP3390645B1 (en) 2016-02-23 2022-09-14 Salk Institute for Biological Studies Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
WO2017147265A1 (en) 2016-02-23 2017-08-31 Salk Institute For Biological Studies High throughput assay for measuring adenovirus replication kinetics
AU2017375633C1 (en) 2016-12-12 2023-04-27 Salk Institute For Biological Studies Tumor-targeting synthetic adenoviruses and uses thereof
WO2018118967A1 (en) 2016-12-21 2018-06-28 Memgen, Llc Armed replication-competent oncolytic adenoviruses
SI3645551T1 (sl) 2017-06-27 2024-06-28 Regeneron Pharmaceuticals, Inc. S tropizmi spremenjeni rekombinantni virusni vektorji in njihova uporaba za tarčni vnos genetskega materiala v človeške celice
BR112020019942A2 (pt) 2018-04-09 2021-01-26 Salk Institute For Biological Studies composições de adenovírus oncolítico com propriedades de replicação aprimoradas
US11542526B2 (en) 2019-02-21 2023-01-03 Unleash Immuno Oncolytics, Inc. Oncolytic adenoviral vector and methods of use
EP4051903A1 (en) 2019-10-29 2022-09-07 Quantum-Si Incorporated Peristaltic pumping of fluids and associated methods, systems, and devices

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9223084D0 (en) * 1992-11-04 1992-12-16 Imp Cancer Res Tech Compounds to target cells
US5846782A (en) * 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US5770442A (en) * 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
AU726544B2 (en) * 1995-12-08 2000-11-09 University Of Alabama At Birmingham Research Foundation, The Targeted adenovirus vectors
EP1180932B1 (en) * 1999-05-12 2012-01-11 The Uab Research Foundation Infectivity-enhanced conditionally-replicative adenovirus and uses thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006514538A (ja) * 2002-07-10 2006-05-11 トランスジーン ソシエテ アノニム 細胞受容体への結合が除去された改変アデノウイルス繊維
JP2015511822A (ja) * 2012-03-13 2015-04-23 ソーク インスティテュート フォー バイオロジカル スタディーズ アデノウイルスおよび化学二量体を用いる選択細胞の標的化

Also Published As

Publication number Publication date
US20020081280A1 (en) 2002-06-27
NO20003956D0 (no) 2000-08-04
WO1999039734A1 (en) 1999-08-12
CA2327545A1 (en) 1999-08-12
CN1304316A (zh) 2001-07-18
KR20010034487A (ko) 2001-04-25
BR9908613A (pt) 2000-10-31
IL137681A0 (en) 2001-10-31
AU744252B2 (en) 2002-02-21
US7297542B2 (en) 2007-11-20
EP1053013A4 (en) 2004-12-22
AU2659599A (en) 1999-08-23
NO20003956L (no) 2000-10-05
EP1053013A1 (en) 2000-11-22

Similar Documents

Publication Publication Date Title
US7297542B2 (en) Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
JP2002507391A5 (cg-RX-API-DMAC10.html)
AU684220B2 (en) Recombinant adenovirus comprising a chimeric penton base protein
Wickham et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
AU698254B2 (en) Chimeric adenoviral fiber protein and methods of using same
EP1181382B1 (en) Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration
WO1994017832A1 (en) Targeting and delivery of genes and antiviral agents into cells by the adenovirus penton
JP2002523105A (ja) 異種遺伝子の運搬用の標的化アデノウイルスベクター
JPH11501219A (ja) 細胞への遣伝子導入のためのベクターおよび方法
EP1002119A1 (en) Targeted hsv vectors
JP2003514526A (ja) 永久羊膜細胞株、その生成、および遺伝子移入ベクターの生成のための使用
JP2003531609A (ja) 目に関する形質導入用ベクターおよび遺伝子治療を目的とするその用途
JP2001503250A (ja) 束縛ペプチドモチーフを用いたターゲッティングアデノウイルス
Sharma et al. Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model
CA2317941A1 (en) Adenoviral vectors with modified capsid proteins
JP2003534805A (ja) 変化した親和性を有する改変ウシアデノウイルス
JP2007503843A (ja) アデノウイルス親和性の拡大
EP1593742A2 (en) Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection
US6815200B1 (en) Modified adenovirus containing a fiber replacement protein
MXPA00007721A (en) Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
NZ505950A (en) Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
JP2003514577A (ja) 改変アデノウイルス繊維および使用
Denby et al. 127. Adenovirus type 5 vectors pseudotyped with fibers from subgroup D (19p and 37) show detargeting from hepatocytes in vitro and in vivo
Roy et al. 128. Use of chimeric adenoviral vectors to assess capsid neutralization determinants
MXPA98004203A (en) Vectors and methods for gene transfer acelu

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060206

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20081104

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090421